Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%

HALOPERIDOL vs COMBINATIONS: e. HALOPERIDOL + RISPERIDONE

Global outcome · psychosis‐induced aggression or agitation

HALOPERIDOL showed no clear difference in global outcome compared with COMBINATIONS: e. HALOPERIDOL + RISPERIDONE (low certainty).

1 finding from 1 review

Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) 2017 · Cochrane Headline outcomes only
RR 0.38 [0.11, 1.33]
1 study · 100 participants
Low

HALOPERIDOL vs COMBINATIONS: h. RISPERIDONE + CLONAZEPAM

Global outcome · psychosis‐induced aggression or agitation

HALOPERIDOL showed no clear difference in global outcome compared with COMBINATIONS: h. RISPERIDONE + CLONAZEPAM (low certainty).

1 finding from 1 review

Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) 2017 · Cochrane Headline outcomes only
RR 0.6 [0.15, 2.38]
1 study · 100 participants
Low

HALOPERIDOL vs RISPERIDONE

Global outcome ‐ rated as severe ‐ CGI‐S · patients with psychosis‐induced aggression or agitation

It is very uncertain whether HALOPERIDOL changes global outcome ‐ rated as severe ‐ CGI‐S compared with OTHER ANTIPSYCHOTIC: h. RISPERIDONE (very low certainty).

1 finding from 1 review

Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation) 2017 · Cochrane Headline outcomes only
RR 0.89 [0.51, 1.58]
1 study · 162 participants
Very low